Study Outcome |
Baseline QoL |
Follow-up QoL |
Baseline safety |
Follow-up safety |
Follow-up efficacy |
Variable |
|
|
|
|
|
Age |
r=-0.413 |
- |
- |
- |
- |
|
P-value <0.0001** |
|
|
|
|
Siblings with epilepsy |
r=-0.276 |
- |
- |
- |
- |
|
P-value
< 0.05*
|
|
|
|
|
Number of medications |
r=-0.421 |
r=-0.409 |
r=0.318 |
r=0.259 |
r=0.240 |
|
P-value <0.0001**
|
P-value <0.0001**
|
P-value
<0.01**
|
P-value
<0.05**
|
P-value
<0.05**
|